Huo, Meirong
China Pharmaceutical University,
China
2025 Rank: 317899
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 2641 out of 157499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 317899 | 358697 |
| Total Cites | 605 | 612 |
| H-index | 10 | 10 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 68 | 69 |
| Number of Single+First+Last Authored Papers | 46 | 46 |
| Total Cites to Single+First+Last Authored Papers | 148 | 151 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 583 | 587 |
| Ratio of Total Citations to Distinct Citing Papers | 1.04 | 1.04 |
| Self-Citation Percentage |
1.14%
|
|
Huo, Meirong
China Pharmaceutical University,
China
2024 Rank: 290675
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Biomedical Engineering
Rank in SubField 1: 2371 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 290675 | 306553 |
| Total Cites | 645 | 656 |
| H-index | 9 | 10 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 67 | 70 |
| Number of Single+First+Last Authored Papers | 45 | 45 |
| Total Cites to Single+First+Last Authored Papers | 149 | 154 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 610 | 616 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.06 |
| Self-Citation Percentage |
1.68%
|
|
Huo, Meirong
China Pharmaceutical University,
China
2023 Rank: 260179
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 2098 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 260179 | 298671 |
| Total Cites | 623 | 633 |
| H-index | 11 | 11 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 60 | 62 |
| Number of Single+First+Last Authored Papers | 43 | 43 |
| Total Cites to Single+First+Last Authored Papers | 151 | 158 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 596 | 601 |
| Ratio of Total Citations to Distinct Citing Papers | 1.05 | 1.05 |
| Self-Citation Percentage |
1.58%
|
|
Huo, Meirong
China Pharmaceutical University,
China
2022 Rank: 211489
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 1669 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 211489 | 233964 |
| Total Cites | 689 | 702 |
| H-index | 11 | 12 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 69 | 72 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 166 | 171 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 654 | 663 |
| Ratio of Total Citations to Distinct Citing Papers | 1.05 | 1.06 |
| Self-Citation Percentage |
1.85%
|
|
Huo, Meirong
China Pharmaceutical University,
China
2021 Rank: 237229
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 1873 out of 131063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 237229 | 269832 |
| Total Cites | 1038 | 1054 |
| H-index | 13 | 13 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 102 | 106 |
| Number of Single+First+Last Authored Papers | 37 | 37 |
| Total Cites to Single+First+Last Authored Papers | 234 | 242 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 977 | 988 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.07 |
| Self-Citation Percentage |
1.52%
|
|
Huo, Meirong
China Pharmaceutical University,
China
2020 Rank: 205044
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 1450 out of 94611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 205044 | 226979 |
| Total Cites | 719 | 735 |
| H-index | 11 | 12 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 77 | 81 |
| Number of Single+First+Last Authored Papers | 34 | 34 |
| Total Cites to Single+First+Last Authored Papers | 226 | 237 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 670 | 678 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.08 |
| Self-Citation Percentage |
2.18%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.